References
Telek HH, Yesilirmak N, Sungur G et al (2017) Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis. Doc Ophthalmol 135:187–194
Abou-Ltaif S (2015) Unusual fundus autofluorescence appearance in a patient with hydroxychloroquine retinal toxicity. Case Rep Ophthalmol 6:186–190
Marmor MF, Kellner U, Lai TY et al (2016) American academy of ophthalmology. Recommendations on screening for chloroquine and hydroxychloroquine retinopthy. Ophthalmol 123:1386–1394
Melles RB, Marmor MF (2014) The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol 132:1453–1460
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Authors have no Conflict of Interests.
Rights and permissions
About this article
Cite this article
Yesilirmak, N., Telek, H.H., Sungur, G. et al. Response to risk of hydroxychloroquine retinopathy is not related to systemic lupus erythematosus or rheumatoid arthritis. Doc Ophthalmol 136, 95–96 (2018). https://doi.org/10.1007/s10633-018-9624-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10633-018-9624-3